Cargando…
Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
Mutation-derived neoantigens are taking central stage as a determinant in eliciting effective antitumor immune responses following adoptive T-cell therapies. These mutations are patient-specific, and their targeting calls for highly personalized pipelines. The promising clinical outcomes of tumor-in...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333784/ https://www.ncbi.nlm.nih.gov/pubmed/32695101 http://dx.doi.org/10.3389/fimmu.2020.01215 |